Zobrazeno 1 - 10
of 122
pro vyhledávání: '"TOMOAKI TERAKAWA"'
Autor:
Taisuke Tobe, Tomoaki Terakawa, Yoshiko Ueno, Keitaro Sofue, Takuto Hara, Junya Furukawa, Jun Teishima, Yuzo Nakano, Kenichi Harada, Masato Fujisawa
Publikováno v:
IJU Case Reports, Vol 7, Iss 1, Pp 30-33 (2024)
Introduction Leiomyosarcoma of the inferior vena cava is associated with poor prognosis. Complete resection is the only curative treatment. We present a patient with this disease in whom cine magnetic resonance imaging was valuable in selecting the s
Externí odkaz:
https://doaj.org/article/327cfac7aeb642c6912f9ad1d10f9592
Autor:
Takuto Hara, Junya Furukawa, Takahiro Tsutiya, Takayuki Kodama, Keiichiro Uehara, Tomoaki Terakawa, Kenichi Harada, Jun Teishima, Yuzo Nakano, Masato Fujisawa
Publikováno v:
IJU Case Reports, Vol 7, Iss 1, Pp 60-63 (2024)
Introduction Renal cell carcinoma with an inferior vena cava tumor thrombus is a challenging disease that requires a multimodal treatment approach. Pembrolizumab plus lenvatinib has displayed promising efficacy in metastatic renal cell carcinoma. Cas
Externí odkaz:
https://doaj.org/article/b26d5065bd0643e0b16a099d8f767376
Autor:
Hideto Ueki, Tomoaki Terakawa, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Junya Furukawa, Yuzo Nakano, Masato Fujisawa
Publikováno v:
IJU Case Reports, Vol 6, Iss 6, Pp 357-361 (2023)
Introduction The performance of robot‐assisted laparoscopic pyeloplasty has recently been increasing in frequency. However, patients with duplicated renal pelvises and ureters can present challenges. Case presentation A 71‐year‐old woman presen
Externí odkaz:
https://doaj.org/article/c338783fbcc24a4b8f703e5981ed0e6a
Autor:
Hideto Ueki, Koichi Kitagawa, Mako Kato, Shihoko Yanase, Yasuyoshi Okamura, Yukari Bando, Takuto Hara, Tomoaki Terakawa, Junya Furukawa, Yuzo Nakano, Masato Fujisawa, Toshiro Shirakawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Recently, immune checkpoint inhibitor (ICI) based combination therapies, including anti-PD-1 antibody, nivolumab with anti-CTLA-4 antibody, and ipilimumab have become the primary treatment option for metastatic or unresectable renal cell car
Externí odkaz:
https://doaj.org/article/7fe93da284264bc099e20e75187ea979
Autor:
Hanako Nishimoto, Atsuyuki Inui, Yutaka Mifune, Kohei Yamaura, Yukari Bando, Yasuyoshi Okamura, Takuto Hara, Tomoaki Terakawa, Ryosuke Kuroda
Publikováno v:
Medicina, Vol 60, Iss 4, p 551 (2024)
Background and Objectives: Androgen deprivation therapy (ADT) for prostate cancer has greatly improved treatment outcomes. As patient survival rates have increased, reports of decreased bone density and increased bone fractures as side effects of ADT
Externí odkaz:
https://doaj.org/article/10451928ffe643c980aecac5533fd1a6
Autor:
Hideto Ueki, Takuto Hara, Yasuyoshi Okamura, Yukari Bando, Tomoaki Terakawa, Junya Furukawa, Kenichi Harada, Yuzo Nakano, Masato Fujisawa
Publikováno v:
Investigative and Clinical Urology, Vol 63, Iss 4, Pp 415-424 (2022)
Purpose: Two methods are used to identify sarcopenia by calculating skeletal muscle area on computed tomography: the skeletal muscle index (SMI) and the psoas muscle index (PMI). Programmed death (PD)-1 inhibitors are helpful in treating metastatic r
Externí odkaz:
https://doaj.org/article/51d31060bc354668aae9fb3622286015
Autor:
Masato Fujisawa, Kenichi Harada, Yasumasa Kakei, Hideaki Miyake, Yuzo Nakano, Tomoaki Terakawa, Keiko Miyakoda
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction This is a multicentre, open-label, single-arm clinical trial to evaluate the efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer.Methods and analysis The trial will be performed at 4 univer
Externí odkaz:
https://doaj.org/article/0986c3087c0f491f85e5ef1514c76946
Autor:
Daichi Fujii, Hikari Shimoda, Natsumi Uehara, Takeshi Fujita, Masanori Teshima, Hirotaka Shinomiya, Akinobu Kakigi, Tomoaki Terakawa, Masato Fujisawa, Ken-ichi Nibu
Publikováno v:
Acta Oto-Laryngologica Case Reports, Vol 6, Iss 1, Pp 1-5 (2021)
Metastasis of malignant tumors to the temporal bone is relatively rare. We report a case of facial nerve palsy due to the metastatic prostatic cancer to the temporal bone with favorable and functional results. A 76-year-old man with no history of mal
Externí odkaz:
https://doaj.org/article/3e4a32ebe4b94443aba246b6a95f6239
Autor:
Hitomi Hara, Teruya Kawamoto, Naomasa Fukase, Ryoko Sawada, Shuichi Fujiwara, Shunsuke Yahiro, Tomohiro Miyamoto, Tomoaki Terakawa, Yutaka Mifune, Yuichi Hoshino, Kenichiro Kakutani, Tomoyuki Matsumoto, Takehiko Matsushita, Takahiro Niikura, Ryosuke Kuroda, Toshihiro Akisue
Publikováno v:
European Journal of Surgical Oncology. 49:928-933
The introduction of tyrosine kinase inhibitors has revolutionized treatment strategies for metastatic renal cell carcinoma (RCC) and has improved survival rates. The number of patients with bone metastases from RCC requiring surgery will increase as
Autor:
Yukari Bando, Junya Furukawa, Takuto Hara, Yasuyoshi Okamura, Tomoaki Terakawa, Yuzo Nakano, Masato Fujisawa
Publikováno v:
Urologia Internationalis. 107(3):321-326
Combination therapies of an immune checkpoint inhibitor and a molecular targeted agent are widely accepted as an appropriate initial systemic therapy for metastatic renal cell carcinoma (RCC), but there is little published evidence regarding the effi